TITLE

Getting the Most Out of Your Pharmacy and Therapeutics Committee

AUTHOR(S)
Sanborn, Michael
PUB. DATE
November 2007
SOURCE
Hospital Pharmacy;Nov2007, Vol. 42 Issue 11, p1077
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article offers information of the Pharmacy and Therapeutics (P&T) Committee of hospitals. It cites that the committee is essential to the goal of providing patients with the safest and most effective medication therapy possible. It is responsible for the review and analysis of all medication errors, errors associated with devices that deliver medications, pharmacist interventions and adverse drug reactions. It also plays a role in medication-use evaluations.
ACCESSION #
27587067

 

Related Articles

  • Medication reconciliation improved, adverse events decreased.  // Drug Formulary Review;Jan2008, Vol. 24 Issue 1, p1 

    The article discusses research on the impact of having a pharmacist make rounds with a medicine team on the accuracy of mediation reconciliation and medical errors. The study was conducted with 45 adult patients who were taking at least three chronic medications. Information is presented on the...

  • Ask what medications EMS has given in field.  // ED Nursing;Dec2008, Vol. 12 Issue 2, p15 

    The article reports on the prescription of fentanyl to adults. Joan Somes of the St. Joseph's Hospital in St. Paul, Minnesota, explains that since effect of fentanyl takes about twice as long in the older adult, medics usually repeat dose of this drug before the patient has a response to the...

  • Concordance of Severity Ratings Provided in Four Drug Interaction Compendia. Abarca, Jacob; Malone, Daniel C.; Armstrong, Edward P.; Grizzle, Amy J.; Hansten, Philip D.; Van Bergen, Robin C.; Lipton, Richard B. // Journal of the American Pharmacists Association: JAPhA;Mar/Apr2004, Vol. 44 Issue 2, p136 

    Objective: To evaluate the agreement among drug-drug interaction (DDI) compendia as to designation of interactions as having the greatest clinical importance ("major" DDIs). Design: Cross-sectional, one-time evaluation. Setting: United States in fall 2001. Participants: Not applicable. ...

  • Impact of contact isolation for multidrug-resistant organisms on the occurrence of medical errors and adverse events. Zahar, J.; Garrouste-Orgeas, M.; Vesin, A.; Schwebel, C.; Bonadona, A.; Philippart, F.; Ara-Somohano, C.; Misset, B.; Timsit, J. // Intensive Care Medicine;Dec2013, Vol. 39 Issue 12, p2153 

    Contact isolation of infected or colonised hospitalised patients is instrumental to interrupting multidrug-resistant organism (MDRO) cross-transmission. Many studies suggest an increased rate of adverse events associated with isolation. We aimed to compare isolated to non-isolated patients in...

  • Identification of Serious Drug-Drug Interactions: Results of the Partnership to Prevent Drug-Drug Interactions. Malone, Daniel C.; Abarca, Jacob; Hansten, Philip D.; Grizzle, Amy J.; Armstrong, Edward P.; Van Bergen, Robin C.; Duncan-Edgar, Babette S.; Solomon, Steven L.; Lipton, Richard B. // Journal of the American Pharmacists Association: JAPhA;Mar/Apr2004, Vol. 44 Issue 2, p142 

    Objective: To develop a list of clinically important drug-drug interactions (DDIs) likely to be encountered in community and ambulatory pharmacy settings and detected by a computerized pharmacy system. Design: Cross-sectional, one-time evaluation. Setting: United States in fall 2001. ...

  • Pharmacist's intervention improves medication use in outpatients.  // Australian Journal of Pharmacy;Oct2009, Vol. 90 Issue 1073, p67 

    The article reports on the effects of pharmacist's intervention on the medication use in outpatients. It states that a pooled analysis was implemented out of two randomised controlled trials to find out effects of pharmacist intervention on adverse drug events and drug errors. The study suggests...

  • Incidence of Adverse Drug Events and Medication Errors in Japan: the JADE Study. Morimoto, Takeshi; Sakuma, Mio; Matsui, Kunihiko; Kuramoto, Nobuo; Toshiro, Jinichi; Murakami, Junji; Fukui, Tsuguya; Saito, Mayuko; Hiraide, Atsushi; Bates, David W. // JGIM: Journal of General Internal Medicine;Feb2011, Vol. 26 Issue 2, p148 

    BACKGROUND: The epidemiology of adverse drug events (ADEs) and medication errors has received little evaluation outside the U.S. and Europe, and extrapolating from these data might not be valid, especially regarding selecting and prioritizing solutions. OBJECTIVE: To assess the incidence and...

  • Adverse Events--at Home and at the Hospital.  // HealthFacts;Aug2008, Vol. 33 Issue 8, p6 

    The article cites two studies on the prevalence of adverse events in hospitals in the U.S. The study involving 998 hospital patients, who were randomly chosen in Massachusetts in 2003, reviewed the medical records of these patients and found 128 adverse events, but rose to 304 when they were...

  • FIRST STOP: YOUR CLINIC.  // Getting the Most from Your Medications;2002, p8 

    The article discusses the management of medication. Get both the brand name and the generic name in writing. Update this record at least once a year, especially if you're seeing more than one doctor. If you're planning any kind of surgery (including dental surgery), give your doctor or...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics